REHOVOT, Israel, Feb. 17, 2021 /PRNewswire/ -- Evogene Ltd.
(NASDAQ: EVGN) (TASE: EVGN), a leading computational biology
company aiming to revolutionize life-science product development
across several market segments, announces today that it will
release its financial results for the fourth quarter and full year
of 2020 on Wednesday, March 3rd,
2021. Dr. Arnon Heyman, Chief
Executive Officer of Evogene's medical cannabis subsidiary, Canonic
Ltd., will join the conference call to discuss Canonic's
activity.
On the day of the announcement, the Company's management will
host a conference call to discuss the results at 09:00 AM Eastern time, 16:00 Israel time. To access the conference call,
please dial +1-888-281-1167 toll free from the United States, or +972-3-918-0609
internationally. Access to the call will also be available via live
webcast through the Company's website at www.evogene.com.
A replay of the conference call will be available approximately
two hours following the completion of the call. To access the
replay, please dial 1-888-326-9310 toll free from the United States, or +972-3-925-5901
internationally. The replay will be accessible through March 5th, 2021, and an archive of the
webcast will be available on the webcast link for the following
twelve months.
About Evogene Ltd.:
Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational
biology company focused on revolutionizing product discovery and
development in multiple life-science based industries, including
human health and agriculture, through the use of its broadly
applicable Computational Predictive Biology (CPB) platform.
The CPB platform, incorporating a deep understanding of biology
leveraged through the power of Big Data and Artificial
Intelligence, has been designed to computationally discover and
guide the development of life-science products based on microbes,
small molecules and genetic elements. Utilizing the CPB
platform, Evogene and its subsidiaries are now advancing product
pipelines for human microbiome-based therapeutics through Biomica
Ltd., medical cannabis through Canonic Ltd., ag-biologicals through
Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and
ag-solutions for castor oil production through Casterra Ltd.
For more information, please
visit www.evogene.com.
Evogene Investor Contact:
Aviva Banczewski / Rivka
Neufeld
Investor Relations and Public Relations Manager
E: IR@evogene.com
T: +972-8-931-1900
US Investor Relations:
Joseph Green
Edison Group
E: jgreen@edisongroup.com
T: +1 646-653-7030
Laine Yonker
Edison Group
E: lyonker@edisongroup.com
T: +1 646-653-7035
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evogene-financial-results-and-earnings-announcement-schedule-for-the-fourth-quarter-and-full-year-of-2020-301229752.html
SOURCE Evogene